Sopan Pharmaceuticals Limited (SOPL)
Manufacturing · Rs. 615.00 15.00 (+2.50%) as of Oct 16, 2026
Price — last 6 months
Full chart →Open
600.00
High / Low
615.00 / 600.00
Prev. close
600.00
Volume
15,208
52-week high
—
52-week low
—
Market cap
—
Shares outstanding
—
MASTER score
Mechanical 0–100 technical ranking. Methodology →
Promoter holding—
Public holding—
Stock performance
1-week change
0.00%
1-month change
-19.08%
3-month change
-25.28%
6-month change
—
YTD change
—
1-year change
—
1-month high
768.00
1-month low
600.00
From 52-week high
—
From 52-week low
—
180-day avg price
761.50
360-day avg price
761.50
Avg volume (1w)
17,198
Avg volume (1m)
23,386
Avg volume (6m)
41,918
Avg volume (12m)
41,918
Daily volatility (1m)
1.55%
Beta vs NEPSE (1y)
1.95
Valuation
EPS (annualized)
—
EPS (TTM)
—
P/E
—
P/B
—
Book value / share
—
ROE
—
ROA
—
Net profit margin
—
Graham number
—
Dividend yield
—
Dividend
—
P/E and P/B use the latest close over per-share values from the company's most recent filed statement. Full dividend history →
Key indicators vs Manufacturing
EPS (Rs.)
N/A
min -6.29avg 452.86max 1,712.27
—
P/E
N/A
min 21.84avg 34.91max 48.67
—
P/B
N/A
min 2.16avg 5.13max 9.26
—
Networth / Share (Rs.)
N/A
min 98.04avg 1,518.08max 5,537.13
—
ROE (%)
N/A
min 0.00avg 10.89max 30.92
—
Technical indicators
| RSI (14) | 29.16 | Oversold |
| MACD | -38.75 | Bearish |
| EMA 5 | 611.78 | Bullish |
| EMA 20 | 655.92 | Bearish |
| EMA 180 | — | — |
| SMA 50 | 728.92 | Bearish |
| SMA 200 | — | — |
Pivot levels (classic)
S3
590.00S2
595.00S1
605.00PP
610.00R1
620.00R2
625.00R3
635.00Key financials — last 8 quarters
worsebetter vs same quarter last yearamounts in Rs · per-share in RsNo filed statements found.
More Manufacturing stocks
SOPL — frequently asked questions
What is Sopan Pharmaceuticals Limited's share price?
Rs. 615.00 as of Oct 16, 2026, the latest NEPSE trading session (+2.50% on the day).
What dividend did SOPL pay?
No dividend on record for the most recent fiscal year in our data.
Prices from the latest NEPSE session; fundamentals from the company's published quarterly statements. Research reference only — not investment advice.